-
Je něco špatně v tomto záznamu ?
Antileukotrienic N-arylethyl-2-arylacetamides in the treatment of ulcerative colitis
R Junek, B Brunova, M Kverka, V Panajotova, A Jandera, M Kuchar
Jazyk angličtina Země Francie
- MeSH
- acetamidy farmakologie chemická syntéza terapeutické užití MeSH
- edém farmakoterapie chemicky indukované MeSH
- financování organizované MeSH
- hydrofobní a hydrofilní interakce MeSH
- krysa rodu rattus MeSH
- leukotrien B4 antagonisté a inhibitory biosyntéza MeSH
- modely nemocí na zvířatech MeSH
- neutrofily metabolismus účinky léků MeSH
- receptory leukotrienu B4 antagonisté a inhibitory metabolismus MeSH
- ulcerózní kolitida farmakoterapie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
A series of arylacetic acid derivatives bearing methyl(arylethyl)amino groups were prepared and their antileukotrienic activities involving LTB(4) were evaluated. Regression analysis has shown a strong dependence of these activities on lipophilicity for both LTB(4) receptor binding and inhibition of LTB(4) biosynthesis; parabolic relationships were derived. The values of slopes of the ascending linear parts of these dependences indicate various types of hydrophobic binding at the site of ligand interaction with relevant biomacromolecules. The anti-inflammatory effect of the compounds under study was also evaluated in three animal models of inflammation and their possible utilization in the treatment of ulcerative colitis (UC) was followed. The importance of antileukotrienic activities for the anti-inflammatory effect, especially in the model of UC was discussed, but further experiments are necessary to confirm the respective relations.
- 000
- 02752naa 2200469 a 4500
- 001
- bmc10010910
- 003
- CZ-PrNML
- 005
- 20121203121104.0
- 008
- 100507s2007 fr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Junek, Richard $7 xx0103668
- 245 10
- $a Antileukotrienic N-arylethyl-2-arylacetamides in the treatment of ulcerative colitis / $c R Junek, B Brunova, M Kverka, V Panajotova, A Jandera, M Kuchar
- 314 __
- $a Zentiva VUFB, a.s., 102 01 Prague 10, Czech Republic.
- 520 9_
- $a A series of arylacetic acid derivatives bearing methyl(arylethyl)amino groups were prepared and their antileukotrienic activities involving LTB(4) were evaluated. Regression analysis has shown a strong dependence of these activities on lipophilicity for both LTB(4) receptor binding and inhibition of LTB(4) biosynthesis; parabolic relationships were derived. The values of slopes of the ascending linear parts of these dependences indicate various types of hydrophobic binding at the site of ligand interaction with relevant biomacromolecules. The anti-inflammatory effect of the compounds under study was also evaluated in three animal models of inflammation and their possible utilization in the treatment of ulcerative colitis (UC) was followed. The importance of antileukotrienic activities for the anti-inflammatory effect, especially in the model of UC was discussed, but further experiments are necessary to confirm the respective relations.
- 650 _2
- $a acetamidy $x farmakologie $x chemická syntéza $x terapeutické užití $7 D000081
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ulcerózní kolitida $x farmakoterapie $7 D003093
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a edém $x farmakoterapie $x chemicky indukované $7 D004487
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a leukotrien B4 $x antagonisté a inhibitory $x biosyntéza $7 D007975
- 650 _2
- $a neutrofily $x metabolismus $x účinky léků $7 D009504
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a receptory leukotrienu B4 $x antagonisté a inhibitory $x metabolismus $7 D018102
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Brůnová, Bohumila. $7 _AN051977
- 700 1_
- $a Kverka, Miloslav. $7 xx0208988
- 700 1_
- $a Panajotová, Vladimíra $7 xx0089991
- 700 1_
- $a Jandera, Antonín. $7 _AN051979
- 700 1_
- $a Kuchař, Miroslav, $d 1935- $7 jk01070734
- 773 0_
- $t European Journal of Medicinal Chemistry $w MED00001628 $g Roč. 42, č. 8 (2007), s. 1084-1094 $x 0223-5234
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20100524113108 $b ABA008
- 991 __
- $a 20121203121135 $b ABA008
- 999 __
- $a ok $b bmc $g 724767 $s 587914
- BAS __
- $a 3
- BMC __
- $a 2007 $b 42 $c 8 $d 1084-1094 $i 0223-5234 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a 2010-B2/dkme